These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35496285)

  • 21. Ninjin'yoeito, a traditional Japanese medicine, increases dopamine content in PC12 cells.
    Miyazaki S; Omiya Y; Mizoguchi K
    Biosci Biotechnol Biochem; 2021 Oct; 85(11):2274-2280. PubMed ID: 34529031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined Use of Ninjin'yoeito Improves Subjective Fatigue Caused by Lenalidomide in Patients With Multiple Myeloma: A Retrospective Study.
    Ito T; Konishi A; Tsubokura Y; Azuma Y; Hotta M; Yoshimura H; Nakanishi T; Fujita S; Nakaya A; Satake A; Ishii K; Nomura S
    Front Nutr; 2018; 5():72. PubMed ID: 30186837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late Onset of Cardiac Metastasis of a Melanoma following Nivolumab Immunotherapy.
    Nakamura K; Koga H; Takazawa Y; Omodaka T; Kiniwa Y; Okuyama R
    Case Rep Oncol; 2022; 15(2):654-658. PubMed ID: 35949903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature.
    Ohara N; Kobayashi M; Ohashi K; Ito R; Ikeda Y; Kawaguchi G; Yoneoka Y; Hasegawa G; Takada T
    J Med Case Rep; 2019 Mar; 13(1):88. PubMed ID: 30909965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secondary Adrenal Insufficiency in a Patient with Metastatic Melanoma Treated with Nivolumab.
    Omata W; Nakamura S; Urasaki C; Morita H; Funaishi H; Kobayashi K; Koide H; Tsutsumida A; Matsue H
    Case Rep Dermatol; 2022; 14(1):55-60. PubMed ID: 35496503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation.
    Kudoh C; Arita R; Honda M; Kishi T; Komatsu Y; Asou H; Mimura M
    Psychogeriatrics; 2016 Mar; 16(2):85-92. PubMed ID: 25918972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postoperative Adjuvant Chemotherapy Regimen of CAPOX Combined With Ninjin'yoeito in an Elderly Patient With Stage III Colon Cancer: A Case Report.
    Aomatsu N; Uchima Y; Tsujio G; Miyamoto Y; Okada T; Kurihara S; Matsutani S; Hirakawa T; Iwauchi T; Morimoto J; Yamagata S; Nakazawa K; Nishii T; Tachimori A; Maeda K; Ikeda K; Takeuchi K
    Front Nutr; 2020; 7():57. PubMed ID: 32426365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune checkpoint blocker-related sarcoid-like granulomatous inflammation: a rare adverse event detected in lymph node aspiration cytology of patients treated for advanced malignant melanoma.
    Rodriguez EF; Lipson E; Suresh K; Cappelli LC; Monaco SE; Maleki Z
    Hum Pathol; 2019 Sep; 91():69-76. PubMed ID: 31279873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperprogressive Disease in the Irradiation Field after a Single Dose of Nivolumab for Gastric Cancer: A Case Report.
    Ogata T; Satake H; Ogata M; Hatachi Y; Yasui H
    Case Rep Oncol; 2018; 11(1):143-150. PubMed ID: 29681813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone.
    Afzal MZ; Mabaera R; Shirai K
    J Immunother Cancer; 2018 Feb; 6(1):13. PubMed ID: 29433557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Programmed cell death-1 blockade in kidney carcinoma may induce eosinophilic granulomatosis with polyangiitis: a case report.
    Harada M; Naoi H; Yasuda K; Ito Y; Kagoo N; Kubota T; Ichijo K; Mochizuki E; Uehara M; Matsuura S; Tsukui M; Koshimizu N
    BMC Pulm Med; 2021 Jan; 21(1):6. PubMed ID: 33407304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nivolumab dose escalation triggered immune checkpoint inhibitor-induced colitis after 147 weeks of prolonged stable use in a patient with lung cancer: a case report.
    Soma K; Nishida T; Osugi N; Morimura O; Adachi S; Fujii Y; Sugimoto A; Mukai K; Nakamatsu D; Matsumoto K; Yamamoto M
    Clin J Gastroenterol; 2022 Feb; 15(1):128-133. PubMed ID: 34716545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between Sex and Immune Checkpoint Inhibitor Outcomes for Patients With Melanoma.
    Jang SR; Nikita N; Banks J; Keith SW; Johnson JM; Wilson M; Lu-Yao G
    JAMA Netw Open; 2021 Dec; 4(12):e2136823. PubMed ID: 34854905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Case of Immune Checkpoint Inhibitor Refractory Colitis Treated with Mycophenolate and High-dose Steroids.
    Alcantar D; Al-Jaashaami L; Giron F
    Cureus; 2019 Dec; 11(12):e6392. PubMed ID: 31938669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic study of Ninjin'yoeito: Absorption and brain distribution of Ninjin'yoeito ingredients in mice.
    Matsumoto T; Takiyama M; Sakamoto T; Kaifuchi N; Watanabe J; Takahashi Y; Setou M
    J Ethnopharmacol; 2021 Oct; 279():114332. PubMed ID: 34129897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case Report: Neuromyelitis Optica After Treatment of Uveal Melanoma With Nivolumab and Ipilimumab.
    Khimani K; Patel SP; Whyte A; Al-Zubidi N
    Front Oncol; 2022; 12():806501. PubMed ID: 35402220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Palliative Chemotherapy: Does It Only Provide False Hope? The Role of Palliative Care in a Young Patient With Newly Diagnosed Metastatic Adenocarcinoma.
    Doverspike L; Kurtz S; Selvaggi K
    J Adv Pract Oncol; 2017; 8(4):382-386. PubMed ID: 30018843
    [No Abstract]   [Full Text] [Related]  

  • 38. Nivolumab Induces Sustained Liver Injury in a Patient with Malignant Melanoma.
    Matsubara T; Nishida T; Higaki Y; Tomita R; Shimakoshi H; Shimoda A; Osugi N; Sugimoto A; Takahashi K; Nakamatsu D; Mukai K; Yamamoto M; Fukui K; Adachi S; Inada M
    Intern Med; 2018 Jun; 57(12):1789-1792. PubMed ID: 29434164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Esophageal cancer responsive to the combination of immune cell therapy and low-dose nivolumab: two case reports.
    Takimoto R; Kamigaki T; Gotoda T; Takahashi T; Okada S; Ibe H; Oguma E; Goto S
    J Med Case Rep; 2021 Apr; 15(1):191. PubMed ID: 33827668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination therapy of ipilimumab and nivolumab induced thyroid storm in a patient with Hashimoto's disease and diabetes mellitus: a case report.
    Yonezaki K; Kobayashi T; Imachi H; Yoshimoto T; Kikuchi F; Fukunaga K; Sato S; Ibata T; Yamaji N; Lyu J; Dong T; Murao K
    J Med Case Rep; 2018 Jun; 12(1):171. PubMed ID: 29914537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.